Cargando…

Correction: Neurobiological roots of psychopathy

Detalles Bibliográficos
Autores principales:	Tiihonen, Jari, Koskuvi, Marja, Lähteenvuo, Markku, Virtanen, Pekka L. J., Ojansuu, Ilkka, Vaurio, Olli, Gao, Yanyan, Hyötyläinen, Ida, Puttonen, Katja A., Repo-Tiihonen, Eila, Paunio, Tiina, Rautiainen, Marja-Riitta, Tyni, Sasu, Koistinaho, Jari, Lehtonen, Šárka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7714682/ https://www.ncbi.nlm.nih.gov/pubmed/31570776 http://dx.doi.org/10.1038/s41380-019-0528-8

Ejemplares similares

Neurobiological roots of psychopathy
por: Tiihonen, Jari, et al.
Publicado: (2019)

Female Psychopathy and Mortality
por: Vaurio, Olli, et al.
Publicado: (2022)

Sex-specific transcriptional and proteomic signatures in schizophrenia
por: Tiihonen, Jari, et al.
Publicado: (2019)

Substance Abuse and Excessive Mortality Among Forensic Psychiatric Patients: A Finnish Nationwide Cohort Study
por: Ojansuu, Ilkka, et al.
Publicado: (2019)

Contribution of astrocytes to familial risk and clinical manifestation of schizophrenia
por: Koskuvi, Marja, et al.
Publicado: (2021)

General and violent recidivism of former forensic psychiatric patients in Finland
por: Ojansuu, Ilkka, et al.
Publicado: (2023)

A Systematic Literature Review of Neuroimaging of Psychopathic Traits
por: Johanson, Mika, et al.
Publicado: (2020)

Antipsychotic Polypharmacy in Clozapine Resistant Schizophrenia: A Randomized Controlled Trial of Tapering Antipsychotic Co-treatment
por: Repo-Tiihonen, Eila, et al.
Publicado: (2012)

Comorbid opioid use is undertreated among forensic patients with schizophrenia
por: Kivimies, Kristiina, et al.
Publicado: (2018)

Effects of Substance Use and Antisocial Personality on Neuroimaging-Based Machine Learning Prediction of Schizophrenia
por: Taipale, Matias, et al.
Publicado: (2023)

Antipsychotic Polypharmacy for the Management of Schizophrenia: Evidence and Recommendations
por: Lähteenvuo, Markku, et al.
Publicado: (2021)

Twenty‐year medication use trends in first‐episode bipolar disorder
por: Poranen, Juulia, et al.
Publicado: (2022)

Metabolic alterations in Parkinson’s disease astrocytes
por: Sonninen, Tuuli-Maria, et al.
Publicado: (2020)

Brain structural alterations in autism and criminal psychopathy
por: Noppari, Tuomo, et al.
Publicado: (2022)

Brain Basis of Psychopathy in Criminal Offenders and General Population
por: Nummenmaa, Lauri, et al.
Publicado: (2021)

Efficacy of immersive extended reality (XR) interventions on different symptom domains of schizophrenia spectrum disorders. A systematic review
por: Holopainen, Roope, et al.
Publicado: (2023)

NF‐E2‐related factor 2 activation boosts antioxidant defenses and ameliorates inflammatory and amyloid properties in human Presenilin‐1 mutated Alzheimer's disease astrocytes
por: Oksanen, Minna, et al.
Publicado: (2019)

Aberrant motor contagion of emotions in psychopathy and high-functioning autism
por: Sun, Lihua, et al.
Publicado: (2022)

Genome-wide association study of antisocial personality disorder
por: Rautiainen, M-R, et al.
Publicado: (2016)

Adenosine modulators and calcium channel blockers as add-on treatment for schizophrenia
por: Lintunen, Jonne, et al.
Publicado: (2021)

Primary Nonadherence to Antipsychotic Treatment Among Persons with Schizophrenia
por: Lieslehto, Johannes, et al.
Publicado: (2022)

S210. COMPARATIVE EFFECTIVENESS OF ANTIPSYCHOTICS FOR RISK OF ATTEMPTED OR COMPLETED SUICIDE AMONG PERSONS WITH SCHIZOPHRENIA
por: Taipale, Heidi, et al.
Publicado: (2020)

T208. EFFECTIVENESS OF PHARMACOLOGICAL THERAPIES FOR DELUSIONAL DISORDER
por: Lähteenvuo, Markku, et al.
Publicado: (2020)

Comparative Effectiveness of Antipsychotics for Risk of Attempted or Completed Suicide Among Persons With Schizophrenia
por: Taipale, Heidi, et al.
Publicado: (2020)

Microglia-like Cells Promote Neuronal Functions in Cerebral Organoids
por: Fagerlund, Ilkka, et al.
Publicado: (2021)

Healthcare utilization, costs, and productivity losses in treatment-resistant depression in Finland – a matched cohort study
por: Taipale, Heidi, et al.
Publicado: (2022)

Real-world effectiveness of antidepressant use in persons with schizophrenia: within-individual study of 61,889 subjects
por: Puranen, Arto, et al.
Publicado: (2023)

41.2 WHAT DOES EPIDEMIOLOGICAL DATA TELL US ABOUT CLOZAPINE’S EFFECTIVENESS?
por: Tiihonen, Jari
Publicado: (2018)

Real‐world effectiveness of pharmacological treatments of alcohol use disorders in a Swedish nation‐wide cohort of 125 556 patients
por: Heikkinen, Milja, et al.
Publicado: (2021)

Long-Term Real-World Effectiveness of Pharmacotherapies for Schizoaffective Disorder
por: Lintunen, Jonne, et al.
Publicado: (2021)

Real‐world effectiveness of pharmacological treatments of opioid use disorder in a national cohort
por: Heikkinen, Milja, et al.
Publicado: (2022)

Association of Pharmacological Treatments and Hospitalization and Death in Individuals With Amphetamine Use Disorders in a Swedish Nationwide Cohort of 13 965 Patients
por: Heikkinen, Milja, et al.
Publicado: (2022)

Comparative Effectiveness of Pharmacotherapies for the Risk of Attempted or Completed Suicide Among Persons With Borderline Personality Disorder
por: Lieslehto, Johannes, et al.
Publicado: (2023)

Psychopathic traits among a consecutive sample of Finnish pretrial fire-setting offenders
por: Thomson, Annika, et al.
Publicado: (2015)

Forensic psychiatry in Finland: an overview of past, present and future
por: Seppänen, Allan, et al.
Publicado: (2020)

Psychopathy to Altruism: Neurobiology of the Selfish–Selfless Spectrum
por: Sonne, James W. H., et al.
Publicado: (2018)

What lies underneath: The genetics and neurobiology of psychopathy
por: Lemos, M., et al.
Publicado: (2021)

Cause-specific excess mortality after first diagnosis of bipolar disorder: population-based cohort study
por: Paljärvi, Tapio, et al.
Publicado: (2023)

Dysfunction of Cellular Proteostasis in Parkinson’s Disease
por: Lehtonen, Šárka, et al.
Publicado: (2019)

Morbidity and mortality in schizophrenia with comorbid substance use disorders
por: Lähteenvuo, Markku, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_t18hrgrpe6elqinjgkehonsn05